Search
for
Sort by
Research 961–990 of 1000+
- FOXN1 Is Critical for Onycholemmal Terminal Differentiation in Nude (Foxn1nu) Mice
- The High Prevalence of Skin Diseases in Adults Aged 70 and Older
- Mucocutaneous side effects of antineoplastic chemotherapy
- Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study
- Cutaneous Reactions to Chemotherapeutic Agents
- Acquired Zinc Deficiency Dermatosis in Man
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Alopecia areata: diagnosis and management
- DISORDERS OF THE NAILS AND HAIR ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
- Mutations in KLHL24 Add to the Molecular Heterogeneity of Epidermolysis Bullosa Simplex
- Thyroid hormone action on skin
- Involvement of scalp and nails in lupus erythematosus
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Use of dermatoscopy and videodermatoscopy in therapeutic follow-up: a review
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
- Toxic shock syndrome: Recent developments in pathogenesis
- Ichthyosis follicularis with alopecia and photophobia in a mother and daughter
- Unusual Microsporum canis infections in adult HIV patients
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- Epidermolysis bullosa in animals: a review
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Anthralin/dithranol in dermatology
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Thyroid hormone action on skin
- The spotted lunula
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part I
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs